[Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs].
D002792:Cholestyramine Resin / Q000009:adverse effects / Q000627:therapeutic use; D002994:Clofibrate / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000009:adverse effects / Q000627:therapeutic use; D013974:Thyroxine / Q000009:adverse effects / Q000627:therapeutic use
D000960:Hypolipidemic Agents; D009539:Nicotinic Acids; D002792:Cholestyramine Resin; D002994:Clofibrate; D013974:Thyroxine
Arneimittelwechselwirkungen bei der Behandlung der primären Hyperlipoproteinämien mit antilipidämisch wirksamen Pharmaka